A Case of Isoniazid-induced Thrombocytopenia: Recovery with Immunoglobulin Therapy
의약학 > 내과학
( Seung Hun Lee ) , ( Eun Ju Lee ) , ( You Eun Kim ) , ( Seung Jun Lee ) , ( Yu Ji Cho ) , ( Yi Yeong Jeong ) , ( Ho Cheol Kim ) , ( Jong Deok Lee ) , ( Young Sil Hwang )
대한내과학회 추계학술발표논문집 2011년, 제2011권 제1호, 198(총1쪽)
42846547.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    30원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    A 51-year-old man was diagnosed with pulmonary tuberculosis. Treatment for a 51-year-old man with pulmonary tuberculosis was begun initiated with isoniazid (INH), rifampicin, ethambutol, and pyrazinamide, and but these were discontinued after 3 weeks because of skin rash and itchinessg sensation 3 weeks posttreatment. Isoniazid INH monotherapy was restarted to identify the causative drug after 2 weeks of interruption. Two days laterafter INH administration, his the patient``s platelet count was reduced from 150 x× 103/mm3 to 4 x× 103/mm3. The patients did not improve despite of pPlatelet transfusion and oral corticosteroid administration for 2severe days did not cause any improvement in the patient`s condition. However, his platelet count was recovered with to 209 x× 103/mm3 after 2-day administration of intravenous immunoglobulin (IVIG) was started for two days. This report describesis a case of INH-induced thrombocytopenia due to INH, a rare adverse event, which was recovered reversed with IVIG, highlighting the efficacy of this treatment for this rare indication.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.